A Food Effect Study to Evaluate the Relative Bioavailability of Nalbuphine Extended-Release Tablets (NAL ER) in Healthy Participants

Abroad (travel likely)RecruitingPHASE1

Conditions

Healthy Participants

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Clinical Pharmacology of Miami, LLC., Miami, Florida, United States
Contact: Study coordinator (Hadaza Catala) · hcatala@ergclinical.com · 305-817-2900

Study leads

Chief Development Officer
Study Director
Trevi Therapeutics

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Investigate Safety, Tolerability, and Pharmacokinetics of AZD3974 in Healthy Participants

Healthy Participants

Abroad (travel likely)RecruitingPHASE1

Glendale, United States · Baltimore, United States

A Study to Test How BI 1291583 is Taken up in the Blood of People With and Without Liver Problems

Healthy · Hepatic Impairment

Abroad (travel likely)RecruitingPHASE1

Orlando, United States · Houston, United States

A Study to Assess the Relative Bioavailability of Different Subcutaneous Formulations ofAZD6234

Healthy Participants

Abroad (travel likely)RecruitingPHASE1

Ruddington, United Kingdom

First-in-human Study of Orally Administered KT-579 in Healthy Adult Participants

Healthy Participants

Abroad (travel likely)RecruitingPHASE1

Lincoln, United States